Biotron Overview

  • Status
  • Public
  • Employees
  • 4
  • Stock Symbol
  • BIT
Stock Symbol
  • Share Price
  • $0.04
  • (As of Friday Closing)

Biotron General Information


Biotron Ltd is a biotechnology company. The company is engaged in the funding and management of intermediate and applied biotechnology research and development projects. Its lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of HIV-1 and hepatitis C virus infections. Geographically, it operates only in Australia through biotechnology segment.

Contact Information

Ownership Status
Publicly Held
Financing Status
Primary Industry
Other Industries
Drug Discovery
Stock Exchange
Primary Office
  • 66 Hunter Street
  • Level 2
  • Sydney, New South Wales 2000
  • Australia
+61 (02) 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Biotron Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.04 $0.04 $0.03 - $0.10 $30.6M 702M 1.18M

Biotron Financials Summary

In Thousands,
TTM 31-Mar-2021 FY 2020 30-Jun-2020 FY 2019 30-Jun-2019 FY 2018 30-Jun-2018
EV 29,704 30,457 22,561 4,821
EBITDA (2,405) (1,207) (1,238)
Net Income (2,395) (1,152) (1,234)
Total Assets 5,378 4,102 1,189
Total Debt 30 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Biotron Executive Team (1)

Name Title Board Seat Contact Info
Michelle Miller Chief Executive Officer & Executive Director
To view Biotron’s complete executive team members history, request access »

Biotron Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial